Translate this page into:
Letter to the Editor
doi:
10.4103/sajc.sajc_225_17
Triple primary malignancies in head-and-neck region: A report of four cases
1
Department of Radiation Oncology, Jaypee Hospital, Noida
2
Department of Radiation Oncology, Max Super Speciality Hospital, Delhi-NCR, Delhi
3
Department of Radiation Oncology, All Institute of Medical Science, Rishikesh, Uttrakhand
4
Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
5
Department of Radiation Oncology, Max Super Speciality Hospital, Delhi-NCR, Delhi
*Corresponding author: Dr. Manjari Shah. manjarishah29@gmail.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Bittorf B, Kessler H, Merkel S, Brückl W, Wein A, Ballhausen WG, et al. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol 2001;27:302-13.
- National Cancer Institute. SEER Program Code Manual. 3rd ed. Bethesda (MD): National Cancer Institute; 1998.
- Mehdi I, Shah AH, Moona MS, Verma K, Abussa A, Elramih R, et al. Synchronous and metachronous malignant tumours expect the unexpected. J Pak Med Assoc 2010;60:905-9.
- Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology group study. J Clin Oncol 1992;10:1245-51.